Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02278081Phase 4Unknown
Phase 4, randomised trial of lansoprazole in rhinitis and nasal obstruction (2 arms), sponsored by McGill University Health Centre. Primary endpoint: Improvement of the nasal signs and symptoms at 3 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02278081.